Health Care Related Organization – Page 22

Biotech IPOs Kick Off 2025: Ascentage Pharma Raises $126M, Aardvark Therapeutics Files for IPO

5 months ago talkbio0Tagged Ascentage, biotech, Drug Industry, IPOs, Malignant Neoplasms, Obesity, Order Tubulidentata (organism), Pharma

Biotech IPOs, Ascentage Pharma, Aardvark Therapeutics, Cancer Treatment, Obesity Treatment, Pharmaceutical Industry

AstraZeneca Invests $570M in Canadian Expansion, Creating 700 New Jobs

5 months ago talkbio0Tagged AstraZeneca, Canadian, Clinical Trials, Drug Industry, expansion, Investments, R&D

AstraZeneca, Canadian expansion, $570M investment, 700 new jobs, life sciences, R&D, clinical trials, pharmaceutical industry

Retro Biosciences, Backed by Sam Altman, Seeks $1 Billion to Extend Human Lifespan by 10 Years

5 months ago talkbio0Tagged Altman, Artificial (qualifier value), Biosciences, Biotechnology, Dorsal, Funding, Health care facility, Homo sapiens, Intelligence, Lifespan Extension, Series

Retro Biosciences, Sam Altman, Human Lifespan Extension, Biotechnology, Series A Funding, Artificial Intelligence in Healthcare

Chinese Vaccine Biotech Ab&B Files for IPO, Drawing Attention from GSK, Merck, and Pfizer

5 months ago talkbio0Tagged Ab&B, Bio-Tech, Biotechnology, Chinese vaccine, Drug Industry, IPO, Pfizer, Pfizer/, SmithKline Beecham

Ab&B Bio-Tech, IPO, Chinese vaccine biotech, GSK, Merck, Pfizer, biotechnology, pharmaceutical industry

Samsung Biologics Achieves Record Revenue and Secures Largest Contract to Date

5 months ago talkbio0Tagged Biological Factors, Biosimilars, CDMO, Contract agreement, Drug Industry, Largest, Revenue, Samsung

Samsung Biologics, Record Revenue, Largest Contract, Biosimilars, CDMO, Pharmaceutical Industry

Johnson & Johnson’s Darzalex and Spravato Achieve Milestones: Darzalex Leads Sales, Spravato Surpasses $1 Billion Revenue

5 months ago talkbio0Tagged Darzalex, Johnson and Johnson, Mental Depression, Multiple Myeloma, Pharmaceutical Sales, Revenue Milestones, Spravato

Johnson & Johnson, Darzalex, Spravato, Pharmaceutical Sales, Multiple Myeloma, Depression Treatment, Revenue Milestones

HHS Awards Moderna $590 Million to Expedite Bird Flu Vaccine Development

5 months ago talkbio0Tagged Aves, CHARGE Syndrome, Moderna, mRNA Vaccine, pandemic preparedness, Vaccines

Moderna, HHS, Bird Flu Vaccine, Avian Influenza, mRNA Vaccine, Pandemic Preparedness

FDA Places Clinical Hold on Atara Biotherapeutics’ EBVALLO and ATA3219 Due to Manufacturing Compliance Issues

5 months ago talkbio0Tagged allogeneic T-cell therapies, Atara Biotherapeutics, Biomechanical compliance, Ebvallo, Epstein-Barr virus, GMP, Guanosine Monophosphate, Lupus Erythematosus, Systemic, Manufacturing, Post-transplant lymphoproliferative disorder, Study on Hold, United States Food and Drug Administration

Atara Biotherapeutics, FDA clinical hold, EBVALLO, ATA3219, allogeneic T-cell therapies, manufacturing compliance issues, GMP compliance, Epstein-Barr virus, post-transplant lymphoproliferative disease, non-Hodgkin’s lymphoma, systemic lupus erythematosus.